Find CMO/CDMOs that produce: Biologics
Monoclonal Antibodies

Monoclonal Antibodies
Category
Start new search

Filters

Reset current filters

Selected filters:

Production region
Production scale
Qualifications

Located in:

United States

CDMO-CMO


Monoclonal Antibodies production

Plants in:

United States

Established in: 1933

Production scale:

large

Pioneering in advanced delivery technologies and development solutions.

Extensive global network ensuring supply chain resilience.

Tailored services across biologics, gene therapies, and pharmaceuticals.

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

Replies slower than most

Located in:

United States

CDMO-CMO


Monoclonal Antibodies production

Plants in:

United States

Established in: 2020

Production scale:

medium

Innovative approach to biomanufacturing and complex biologics.

Cutting-edge technology for next-generation therapies.

Strong focus on accelerating the development of transformative medicines.

  • GMP

  • FDA

  • EMA

All certificates

    Replies slower than most

    CDMO-CMO


    Monoclonal Antibodies production

    Plants in:

    United States

    Established in: 2016

    Production scale:

    medium

    small

    Low Volume high value API Fill and Finish Service

    In-line monitoring, SKAN Isolators, Highly Experienced Staff

    Capacity Available, Ready for your API

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies quickly

    Located in:

    Norway

    CDMO-CMO


    Monoclonal Antibodies production

    Plants in:

    Norway

    Established in: 2007

    Production scale:

    small

    large

    Specialized in liquid and semi-solid pharmaceuticals manufacturing.

    Nordic excellence in quality and reliability.

    Flexible production capabilities catering to a wide range of batch sizes.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    Located in:

    Germany

    CDMO-CMO


    Monoclonal Antibodies production

    Plants in:

    Germany

    Established in: 1885

    Production scale:

    large

    Strong heritage in pharmaceutical innovation and biotechnology.

    Comprehensive range of services from early development to commercial supply.

    Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    CDMO-CMO


    Monoclonal Antibodies production

    Plants in:

    India

    Established in: 1989

    Production scale:

    large

    Employees: 5000+

    6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

    R&D Centers with capabilities of ANDAs, DMFs and NDDS

    462+ patents filed for drug substances and polymorphs

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • fda

    Replies quickly

    CDMO-CMO


    Monoclonal Antibodies production

    Plants in:

    India

    Established in: 1998

    Production scale:

    small

    medium

    large

    Employees: 1000

    Facilities with global regulatory compliance

    Customized and Flexible Collaboration Models

    End-to-end drug discovery

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • fda

    • ema

    Replies quickly

    Located in:

    United States

    CDMO-CMO


    Monoclonal Antibodies production

    Plants in:

    United States

    Established in: 1996

    Production scale:

    large

    small

    medium

    Leading in biopharmaceutical development and biologic API production.

    Comprehensive services from cell line development to commercial manufacturing.

    Strong track record in delivering complex and high-quality biologics.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • ema

    • fda

    Looking for CMO/CDMO Services?

    Find a list of providers specializing in CMOs/CDMOs Services for Monoclonal Antibodies. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.

    Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.

    CMO/CDMO - Contract (Development) Manufacturing Organizations

    CDMOs and CMOs are pivotal in the pharmaceutical and biotech industries, offering specialized services in drug development and manufacturing. They assist in scaling up production from laboratory to commercial quantities, while adhering to strict regulatory standards. These organizations play a crucial role in the efficient and cost-effective production of medical and pharmaceutical products, ensuring quality and compliance at every stage.

    Biologics

    Biologics CMOs/CDMOs specialize in the manufacturing and development of biopharmaceutical products, which are typically derived from living organisms or biological sources such as proteins, antibodies, vaccines, and cell therapies.

    Monoclonal Antibodies

    Monoclonal antibodies represent a breakthrough in precision medicine, targeting specific disease markers. Their production, involving cell culture and purification techniques, is crucial for treating cancers, autoimmune disorders, and more, offering targeted, effective therapy.


    Pharmaoffer features a range of Contract Development and Manufacturing Organizations (CDMOs) with expertise in monoclonal antibodies production, a cornerstone of precision medicine. Monoclonal antibodies are designed to target specific disease markers, making them vital in treating a range of conditions including cancers and autoimmune disorders. This includes specialized services in Monoclonal Antibody Manufacturing and Monoclonal Antibody Production.


    Key Services Provided by Our Listed CDMOs:


    • Advanced Cell Culture Techniques: Utilization of sophisticated cell culture methods to produce monoclonal antibodies with high specificity and efficacy. This is a fundamental aspect of antibody production services.

    • Precision Purification Processes: Implementation of state-of-the-art purification techniques to ensure the purity and potency of monoclonal antibodies.

    • Custom Antibody Development: Tailoring monoclonal antibody production to meet specific therapeutic targets and treatment objectives.

    • Quality Control and Regulatory Compliance: Adherence to strict quality control standards and regulatory requirements, ensuring the safety and effectiveness of the monoclonal antibodies.

    • Scalable Manufacturing Solutions: Capability to scale production from clinical trial quantities to large-scale commercial batches, meeting the demands of various healthcare needs.


    Your Partner in Advanced Therapeutic Development

    On Pharmaoffer, you can connect with CDMOs that specialize in the development and manufacturing of monoclonal antibodies. Our platform ensures access to cutting-edge technologies and expertise, essential for the production of targeted, effective therapies in the realm of biologics.